Hygiena expands its food safety testing portfolio


Wednesday, 15 August, 2018

Hygiena expands its food safety testing portfolio

Hygiena has acquired Biomedal’s Food Safety division, which will expand the company’s food safety and environmental sanitation testing portfolio to include gluten intolerant testing.

Biomedal offers a wide range of allergen tests including the GlutenTox product line which contains the highly specific G12 antibody that detects the most immunogenic component that is responsible for gluten intolerance.

The new division, which will continue to be based in Seville, will provide more than 20 specific allergen tests available as a sensitive enzyme linked immunosorbent assay (ELISA) format or a simple dipstick format that can be easily used to verify cleaning efforts and test finished products.

It will continue to use its existing product distribution network under the name Hygiena Diagnóstica España S.L, but Biomedal Food Safety employees will become employees of Hygiena.

“We are excited to welcome the new team to Hygiena and look forward to serving our global food and beverage customers with a wider food safety testing portfolio,” said Steven Nason, Chief Executive Officer of Hygiena. “Our allergen business has been growing rapidly and customers around the world have been asking us for a wider array of allergen tests. With this acquisition of Biomedal Food Safety, we now offer an allergen line that is best in class. We will continue investing in new product research and development and further expand our allergen product portfolio.”

Image credit: ©stock.adobe.com/au/djvstock

Related News

Expanding beyond biscuits: Arnott's acquires Prolife Foods

The Arnott's Group has expanded its 'better-for-you' snacking portfolio with the...

FDA investigates PFAS in seafood

The US Food and Drug Administration (FDA) expands its investigation on per- and polyfluoroalkyl...

Cell-cultured quail moving closer to Australians' plates

FSANZ is undertaking a second round of consultation on a proposed approach to allow cell-cultured...


  • All content Copyright © 2024 Westwick-Farrow Pty Ltd